Migden, M. R., Kheterpal, M., Moody, B., Patel, K., Lionnet, L., Sivam, S., … Farberg, A. S. (2025). Efficacy following discontinuation of sonidegib 200 mg daily treatment in patients with locally advanced basal cell carcinoma: Post hoc analysis of the 42-month BOLT study. J Am Acad Dermatol, 93(2), 468–471. https://doi.org/10.1016/j.jaad.2025.04.030

Migden, Michael R., Meenal Kheterpal, Brent Moody, Kunal Patel, Leonard Lionnet, Sakthivel Sivam, Joe Conti, Nicholas Squittieri, and Aaron S. Farberg. “Efficacy following discontinuation of sonidegib 200 mg daily treatment in patients with locally advanced basal cell carcinoma: Post hoc analysis of the 42-month BOLT study.” J Am Acad Dermatol 93, no. 2 (August 2025): 468–71. https://doi.org/10.1016/j.jaad.2025.04.030.

Migden MR, Kheterpal M, Moody B, Patel K, Lionnet L, Sivam S, et al. Efficacy following discontinuation of sonidegib 200 mg daily treatment in patients with locally advanced basal cell carcinoma: Post hoc analysis of the 42-month BOLT study. J Am Acad Dermatol. 2025 Aug;93(2):468–71.

Migden, Michael R., et al. “Efficacy following discontinuation of sonidegib 200 mg daily treatment in patients with locally advanced basal cell carcinoma: Post hoc analysis of the 42-month BOLT study.” J Am Acad Dermatol, vol. 93, no. 2, Aug. 2025, pp. 468–71. Pubmed, doi:10.1016/j.jaad.2025.04.030.

Migden MR, Kheterpal M, Moody B, Patel K, Lionnet L, Sivam S, Conti J, Squittieri N, Farberg AS. Efficacy following discontinuation of sonidegib 200 mg daily treatment in patients with locally advanced basal cell carcinoma: Post hoc analysis of the 42-month BOLT study. J Am Acad Dermatol. 2025 Aug;93(2):468–471.